ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1534

IgG4 Plasma Cell Infiltration in Granulomatosis with Polyangiitis (formerly Wegener’s) Lung Biopsies

Mollie Carruthers1, Shweta Shinagare2, Arezou Khosroshahi1, Vikram Deshpande2 and John H. Stone1, 1Rheumatology, Massachusetts General Hospital, Boston, MA, 2Pathology, Massachusetts General Hospital, Boston, MA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: diagnosis and immunoglobulin (IG), Wegener's granulomatosis

  • Tweet
  • Email
  • Print
Session Information

Title: Vasculitis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Granulomatosis with polyangiitis (GPA) and IgG4-related disease (IgG4-RD) are both immune-mediated conditions that can involve multiple organ systems. In GPA, IgG4-positive plasma cell infiltration has been reported in the kidneys and upper respiratory tract, leading to potential confusion between these two disorders. We sought to determine the degree of IgG4-positive plasma cell infiltration within lung biopsies from patients with ANCA-positive and ANCA-negative GPA, and compared the histopathological and immunohistochemical findings in GPA to biopsies from patients with IgG4-related pulmonary disease. 

Methods: Patients with GPA (n=154) were identified by searching the pathology database of the Massachusetts General Hospital (MGH) for search terms “lung” and “Wegener’s”. Nine ANCA-positive and 4 ANCA-negative patients with wedge biopsy samples of the lung were selected for further analysis. Their clinical, radiologic, and pathologic data were compared to those of 5 patients with IgG4-related pulmonary disease. Hematoxylin and eosin (H&E) stained slides were reviewed in a blinded manner.  Immunohistochemistry was performed using antibodies to IgG4 and IgG and subsequently counted by averaging 3 high-power fields (hpf). The histopathologic features were compared using Fisher’s exact test and IgG4+ plasma cells counts by unpaired t-tests.

Results: The mean number of IgG4+ plasma cells in lung biopsy samples was higher among the IgG4-RD patients compared to those with GPA.  The mean for the IgG4-RD biopsies was 101 IgG4+ plasma cells/hpf (range: 13-240 IgG4+ cells), compared with 25 cells (range: 0-135) for the GPA patients (P=0.035).  IgG4+ plasma cells were numerically higher among GPA patients who were ANCA-positive as opposed to ANCA-negative (40 vs. 11 cells, respectively).  Three of the 9 ANCA-positive GPA patients  had IgG4+ plasma cell infiltrates that exceeded the minimum number considered characteristic of IgG4-RD in the lung (>50 IgG4+ plasma cells/hpf). 

Comparisons of the histopathologic features between GPA and IgG4-RD are shown in Table 1. Two sets of findings were critical in distinguishing the pulmonary pathology of ANCA-positive GPA and IgG4-RD: 1) Obliterative phlebitis, present in 80% of the IgG4-RD biopsies, was not observed in any GPA cases; and, 2) Features of granulomatous inflammation – histiocytes, granulomas, and multi-nucleated giant cells – were absent in IgG4-RD. 

Conclusion: Lung biopsies from both IgG4-RD and GPA patients are characterized by lymphoplasmacytic infiltrates and IgG4+ plasma cells.  Histopathological features, particularly the finding of obliterative phlebitis in IgG4-RD and the absence of granulomatous inflammation, are essential in distinguishing between these conditions.

Table 1: Lung Histopathologic Features: Granulomatosis with polyangiitis (GPA) versus IgG4-related disease (IgG4-RD).

 

Pathology Features

GPA

IgG4-RD

P-Value

 

GPA

 

 

 

    Neutrophilic Abscesses

6/9 (67%)

0/5 (0)

0.03*

    Histiocytes

8/9 (89%)

0/5 (0)

0.003*

    Giant cells

8/9 (89%)

0/5 (0)

0.003*

    Granulomas

8/9 (89%)

0/5 (0)

0.003*

    Necrotizing granulomas

2/9 (22%)

0/5 (0)

NS

    Vasculitis

3/9 (33%)

0/5 (0)

NS

    Hemorrhage

5/9 (56%)

0/5 (0)

NS

 

 

 

 

IgG4-RD

 

 

 

    Lymphoplasmacytic infiltrate

8/9 (89%)

5/5 (100%)

NS

    Tissue eosinophilia

3/9 (33%)

3/5 (60%)

NS

    Storiform fibrosis

3/9 (33%)

5/5 (100%)

0.03*

    Obliterative phlebitis

0 (0)

4/5 (80%)

0.005*

 

 


Disclosure:

M. Carruthers,
None;

S. Shinagare,
None;

A. Khosroshahi,
None;

V. Deshpande,
None;

J. H. Stone,

Genentech,

5.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/igg4-plasma-cell-infiltration-in-granulomatosis-with-polyangiitis-formerly-wegeners-lung-biopsies/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology